Postdoctoral Scholar Location:
New Orleans, LA
Open Date:
Apr 1, 2024
Close Date:
Apr 14, 2024
Description:
The University welcomes applications for a Postdoctoral Scholar Position - Anticipated Start Date, May 1, 2024 Postdoc is expected to:
Undertake independent research projects in the areas of Monensin in lung cancer cells Gain experience proliferation, migration and colony formation assays in molecular cloning Publish 1-3 first author papers Apply for innovation focused grants Present research at professional meetings and conferences Partial supervision of interns Ad hoc lectures in cancer research Other professional development as as assigned by PI/Faculty Advisor Qualifications: PhD in Pharmacy
Application Instructions: Please submit an application using Interfolio via the 'Apply Now' button on this page.
apply.interfolio.com/143827
Applicants are asked to provide a CV for review by the search committee. You may upload additional materials to your application. Applications will be reviewed on an ongoing basis until April 14th, 2024 or until the position is filled.
If you have any questions about the application process please contact
Equal Employment Opportunity Statement: Tulane University is located in New Orleans - a city with tremendous history of diverse cultures, community, and languages. Tulane University is committed to creating a community and culture that foster a sense of belonging for all. We are a recognized employer and educator valuing AA/EEO, Protected Veterans, and Individuals with Disabilities. We encourage all qualified candidates to apply. We are intentionally seeking candidates who are committed to fostering equity, diversity, and inclusion in support of Tulane's Strategy for Tomorrow . Tulane University is responsible for providing reasonable accommodations to individuals with disabilities throughout the applicant screening process. If you need assistance in completing this application or during any phase of the interview process, please contact the Office of Human Resources & Institutional Equity by phone at or email .